Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_provenance.
- NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_assertion description "[We noted that the activity of the proapoptotic mixed lineage kinase 3 (MLK3) kinase was relatively higher in estrogen receptor-negative (ER(-)) breast tumors, suggesting that E(2) might inhibit MLK3 activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_provenance.
- NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_assertion evidence source_evidence_literature NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_provenance.
- NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_assertion SIO_000772 20145118 NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_provenance.
- NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_assertion wasDerivedFrom befree-2016 NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_provenance.
- NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_assertion wasGeneratedBy ECO_0000203 NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_provenance.
- befree-2016 importedOn "2016-02-19" NP792853.RA3tPcm7XM8x9pOdIxIhe_7jhRaxdU2yuCU2Z0-LHpCpo130_provenance.